Consumer Discretionary • Catalog/Specialty Distribution
$178.57 ▲ +0.73
(+0.41%)
MKT CAP: $5.24B • VOL: 236.6K
52W L $64 52W H $182
NSIT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $8.25B | $8.70B | $9.18B |
| YoY Revenue Growth % | -5.2% | -5.2% | — |
| Gross Profit | $1.76B | $1.77B | $4.04B |
| Gross Margin % | 21.4% | 20.3% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $334.9M | $388.6M | $419.8M |
| Operating Margin % | 4.1% | 4.5% | 4.6% |
| Net Income (GAAP) | $157.3M | $249.7M | $281.3M |
| EBITDA (Normalized) | $354.5M | $426.0M | $750.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $303.8M | $632.8M | $619.5M |
| Capital Expenditures (CapEx) | $24.5M | $46.8M | $412.9M |
| Free Cash Flow (FCF) | $279.3M | $586.1M | $206.6M |
| FCF Margin % | 3.4% | 6.7% | 2.3% |
| Return on Invested Capital (ROIC %) | 5.7% | 7.5% | 5.0% |
| Cash & Short-Term Equivalents | $358.0M | $259.2M | $1.21B |
| Total Debt (Short + Long Term) | $3.35B | $2.56B | $2.58B |
| Total Stockholders' Equity | $1.65B | $1.77B | $5.29B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NSIT.